| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/16/2009 | US7547532 Three-dimensional structure of prostaglandin D synthase and utilization thereof |
| 06/16/2009 | US7547527 Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 06/16/2009 | US7547438 CD40-binding activating antibodies |
| 06/16/2009 | CA2574904C Antiretroviral enantiomeric nucleotide analogs |
| 06/16/2009 | CA2476934C Stabilized tnfr-fc composition comprising arginine |
| 06/16/2009 | CA2388314C Imidazole derivatives as phosphodiesterase vii inhibitors |
| 06/16/2009 | CA2381097C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 06/16/2009 | CA2361936C Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 06/16/2009 | CA2343732C Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto |
| 06/16/2009 | CA2334877C Dietary supplement derived from fermented milks for the prevention of osteoporosis |
| 06/16/2009 | CA2282727C Cell surface molecule mediating cell adhesion and signal transmission |
| 06/16/2009 | CA2266439C Neutrokine .alpha. |
| 06/16/2009 | CA2192786C Cyclopeptolide inhibitors of adhesion molecules |
| 06/11/2009 | WO2009073628A2 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof |
| 06/11/2009 | WO2009073168A1 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof |
| 06/11/2009 | WO2009073146A2 Use of immunomodulatory compounds for the treatment of transverse myelitis, multiple sclerosis, and other disorders |
| 06/11/2009 | WO2009072889A1 Bifidobacterium for dust mite allergy |
| 06/11/2009 | WO2009072635A1 Method for amplifying hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | WO2009072626A1 Method for amplification of hematopoietic stem cell using heterocyclic compound |
| 06/11/2009 | WO2009072625A1 Amplification method for hematopoietic stem cells with heterocyclic compound |
| 06/11/2009 | WO2009072624A1 Method for amplification of hematopoietic stem cell using heterocyclic compound |
| 06/11/2009 | WO2009072136A1 Particulate drug carriers as desensitizing agents |
| 06/11/2009 | WO2009071892A2 Method for the detection of dead and dying cells |
| 06/11/2009 | WO2009071753A1 4-phenyl-1,3-thiazole and 4-phenyl-1,3-oxazole derivatives as cannabinoid receptor ligands |
| 06/11/2009 | WO2009071599A1 Immunotherapeutic method for increasing groundnut tolerance in a subject |
| 06/11/2009 | WO2009071161A1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 06/11/2009 | WO2009033818A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033787A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033786A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033759A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033740A3 Use of a peptide as a therapeutic agent |
| 06/11/2009 | WO2009033722A3 Use of a octreotide as a therapeutic agent |
| 06/11/2009 | WO2009033719A3 Use of a deslorelin and mastoparan as a therapeutic agent |
| 06/11/2009 | WO2008140565A3 Use of tumor necrosis factor receptor 14 antagonists for treating psoriasis |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149548 Novel 1,2-diphenylethene derivatives for treatment of immune diseases |
| 06/11/2009 | US20090149538 Aspirin-Triggered Lipid Mediators |
| 06/11/2009 | US20090149518 Pharmaceutical for protection of motor nerve in patient with amyotrophic lateral sclerosis |
| 06/11/2009 | US20090149502 a mixture of 4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one and an adrenergic agonist selected from the group consisting of albuterol, terbutaline, fenoterol, formoterol and salmeterol, used for the treatment of allergies, skin and respiratory system disorders |
| 06/11/2009 | US20090149459 P38 inhibitors and methods of use thereof |
| 06/11/2009 | US20090149457 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors |
| 06/11/2009 | US20090149447 Novel M3 Muscarinic Acetylcholine Receptor Antagonists |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149430 Composition containing amidine derivatives or carboxamide derivatives and steroids, as a medicament |
| 06/11/2009 | US20090149411 Immunostimulatory oligonucleotides with modified bases and methods of use thereof |
| 06/11/2009 | US20090149410 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/11/2009 | US20090148542 Composition comprising an extract of tiarella polyphylla and tiarellic acid isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity |
| 06/11/2009 | US20090148539 Methods, compositions, and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 06/11/2009 | US20090148510 GPCR crystalization method using an antibody |
| 06/11/2009 | US20090148507 Chimeric polypeptides containing chemokine domains |
| 06/11/2009 | US20090148479 Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein |
| 06/11/2009 | US20090148471 Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen |
| 06/11/2009 | US20090148466 Process for the Preparation of Hypoallergenic Mosaic Antigens |
| 06/11/2009 | US20090148465 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 06/11/2009 | US20090148463 Ivig modulation of chemokines for treatment of multiple sclerosis, alzheimer's disease, and parkinson's disease |
| 06/11/2009 | US20090148462 Methods and compositions for use in treatment of patients with autoantibody positive disease |
| 06/11/2009 | US20090148460 Exosome ligands, their preparation and uses |
| 06/11/2009 | US20090148451 Therapeutic anti-cytomegalovirus compounds |
| 06/11/2009 | US20090148444 Pharmaceutical composition for treating immune diseases |
| 06/11/2009 | US20090148442 COMBINATION OF BLyS INHIBITION AND ANTI-CD 20 AGENTS FOR TREATMENT OF AUTOIMMUNE DISEASE |
| 06/11/2009 | US20090148410 Improving the health of a companion animal; reducing pathogenic bacteria in feces, reducing stress, autoimmune disease, aging, kidney stones |
| 06/11/2009 | US20090148406 Stable Aqueous Systems Comprising Proteins |
| 06/11/2009 | US20090148404 Compositions and methods for eliminating undesired subpopulations of t cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation |
| 06/11/2009 | CA2743682A1 Methods of reducing transplant rejection and cardiac allograft vasculopathy by implanting autologous stem cells |
| 06/11/2009 | CA2708050A1 Method for expanding hematopoietic stem cells using heterocyclic compound |
| 06/11/2009 | CA2707585A1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 06/11/2009 | CA2707013A1 Immunotherapeutic method for increasing groundnut tolerance in a subject |
| 06/11/2009 | CA2706458A1 Process for reducing effects of graft versus host disease using ex vivo expanded cd4+cd25+ regulatory t cells |
| 06/10/2009 | EP2067784A2 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivates as anti-flammatory agents |
| 06/10/2009 | EP2067777A1 Oxepin derivative |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2067487A2 Immunomodulatory formulations and methods for use thereof |
| 06/10/2009 | EP2066633A1 Heteroaromatic compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity |
| 06/10/2009 | EP2066628A1 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 06/10/2009 | EP2066348A1 Compositions and methods for enhancing an adjuvant |
| 06/10/2009 | EP2066332A1 Flu vaccine admixture of mannan and flu antigen |
| 06/10/2009 | EP2066319A1 Benzotriazole kinase modulators |
| 06/10/2009 | EP1482961B1 Use of soluble fgl2 as an immunosuppressant |
| 06/10/2009 | EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 06/10/2009 | EP1319003B1 Xanthine phosphodiesterase v inhibitors |
| 06/10/2009 | EP1242115B1 Chemically-programmable immunity |
| 06/10/2009 | EP0854870B1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN100497639C Means and methods for the production of adenovirus vectors |
| 06/10/2009 | CN100497629C Live vaccine for treating anaphylaxis |
| 06/10/2009 | CN100497628C Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 06/10/2009 | CN100497392C Antagonistic anti-hTNFSF13b Human antibodies |
| 06/10/2009 | CN100497389C Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 06/10/2009 | CN100497388C Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 06/10/2009 | CN100497386C Antibodies of non-functional P2X7 receptor and its uses |
| 06/10/2009 | CN100497379C Protein complex serving as vehicle for orally administerable medicaments |
| 06/10/2009 | CN100497370C Bursopoietin extracting method and its use in disease treating and immune |
| 06/10/2009 | CN100497334C Indole derivatives useful as histamine h3 antagonists |
| 06/10/2009 | CN100497313C New isoquinoline compounds, their preparation method and medicine composition containing them |
| 06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
| 06/10/2009 | CN100496493C 2-amino-4, 5-trisubstituted thiazolyl derivatives |
| 06/10/2009 | CN100496298C Process for producing liquid formulation containing raw yeast and liquid formulation |
| 06/09/2009 | US7544839 N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide; nervous system disorders; melatoninergic system disorders; industrial synthesis |
| 06/09/2009 | US7544835 Carboxylic acid derivative and salt thereof |
| 06/09/2009 | US7544783 Active constituent in antiallergic medicine; block the IgE acceptor; specifically bind to a native IgG inhibitory receptor containing immunoreceptor tyrosine-based inhibitory motif, thereby inhibiting the IgE-driven mediator release from mast cells and basophils |